Pediatric Cancer News

Whole exome sequencing closer to becoming “new family history”Oct 20, 2014
Baylor researchers find one-fourth of patients whose DNA was submitted for clinical whole exome testing received a diagnosis related to a known genetic disease, often ending a long search for answers for them and their parents.
Baylor, Texas Children's Cancer Center research helps determine molecular causes of Langerhans cell histiocytosisSep 12, 2014
Study helps fill in some of the bigger picture of the molecular pathology that leads to LCH, points to some potential therapeutic approaches.
Baylor College of Medicine receives additional $9.7 million in state cancer grantsAug 21, 2014
Baylor College of Medicine received $9.7 million in the newest wave of grants announced by the Cancer Prevention and Research Institute of Texas.
Grants fund Baylor, Texas Children’s Cancer Center research on novel treatments for pediatric cancerAug 11, 2014
St. Baldrick’s Foundation awards nearly $850,000 in grants to Baylor and Texas Children’s Cancer Center physician research to treat pediatric cancer.
Grant supports innovative immunotherapy research at BaylorJun 12, 2014
Alex’s Lemonade Stand Foundation awards Dr. Stephen Gottschalk Innovation Award to support his work to find new treatments for childhood cancer.
Chipping away at the cause behind rare tumorsJun 4, 2014
Baylor researchers part of study that finds uncovered the underlying mutations in intracranial germ cell tumors, which could lead to new therapeutic targets.
Grant funds research into connection between birth defects, childhood cancerMay 1, 2014
Dr. Philip Lupo of Baylor College of Medicine has been awarded a grant from Alex’s Lemonade Stand Foundation for his research that explores the intersection between childhood cancer and birth defects.
Research on rare blood disorder leads to diagnostic test, potential new therapiesMar 20, 2014
A recent study by researchers, including those from Baylor and the Histiocytosis Program at Texas Children’s Cancer Center, has uncovered important advances in the understanding of a rare blood disorder called Langerhans cell histiocytosis.
Study profiles parents’ attitudes on genomic studies, data sharing and privacyMar 11, 2014
Baylor researchers find parents are more concerned about the future risk to their child, when considering enrollment in genetic studies.
Dr. Malcolm Brenner recipient of Pediatric Blood and Marrow Transplant Consortium Lifetime Achievement AwardFeb 13, 2014
Renowned cell and gene therapy researcher Dr. Malcolm Brenner has been named a recipient of the Pediatric Blood and Marrow Transplant Consortium’s Lifetime Achievement Award.